| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
C&R Research Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,660.00 |
| 52 Week High | ₩1,990.00 |
| 52 Week Low | ₩1,078.00 |
| Beta | 0.14 |
| 1 Month Change | 37.99% |
| 3 Month Change | 32.69% |
| 1 Year Change | 36.29% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -34.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| A359090 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | 11.2% | -0.5% | -2.4% |
| 1Y | 36.3% | 1.4% | 1.9% |
Return vs Industry: A359090 exceeded the KR Life Sciences industry which returned 1.4% over the past year.
Return vs Market: A359090 exceeded the KR Market which returned 1.9% over the past year.
Price Volatility
| A359090 volatility | |
|---|---|
| A359090 Average Weekly Movement | 11.6% |
| Life Sciences Industry Average Movement | 7.4% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A359090's share price has been volatile over the past 3 months.
Volatility Over Time: A359090's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 483 | Moontae Yoon | www.cnrres.com |
C&R Research Inc. Fundamentals Summary
| A359090 fundamental statistics | |
|---|---|
| Market cap | ₩91.17b |
| Earnings (TTM) | ₩5.55b |
| Revenue (TTM) | ₩55.10b |
16.4x
P/E Ratio1.7x
P/S RatioIs A359090 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A359090 income statement (TTM) | |
|---|---|
| Revenue | ₩55.10b |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩55.10b |
| Other Expenses | ₩49.55b |
| Earnings | ₩5.55b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 101.04 |
| Gross Margin | 100.00% |
| Net Profit Margin | 10.07% |
| Debt/Equity Ratio | 14.3% |
How did A359090 perform over the long term?
See historical performance and comparison